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Trypanosoma cruzi is the etiologic agent of Chagas’ disease. It is known that
amastigotes derived from trypomastigotes in the extracellular milieu are infective in vitro
and in vivo. Extracellular amastigotes (EAs) have a stage-specific surface antigen
called Ssp-4, a GPI-anchored glycoprotein that is secreted by the parasites. By
immunoprecipitation with the Ssp-4-specific monoclonal antibodies (mAb) 2C2 and
1D9, we isolated the glycoprotein from EAs. By mass spectrometry, we identified
the core protein of Ssp-4 and evaluated mRNA expression and the presence of
Ssp-4 carbohydrate epitopes recognized by mAb1D9. We demonstrated that the
carbohydrate epitope recognized by mAb1D9 could promote host cell invasion by EAs.
Although infectious EAs express lower amounts of Ssp-4 compared with less-infectious
EAs (at the mRNA and protein levels), it is the glycosylation of Ssp-4 (identified by
mAb1D9 staining only in infectious strains and recognized by galectin-3 on host cells)
that is the determinant of EA invasion of host cells. Furthermore, Ssp-4 is secreted by
EAs, either free or associated with parasite vesicles, and can participate in host-cell
interactions. The results presented here describe the possible role of a carbohydrate
moiety of T. cruzi surface glycoproteins in host cell invasion by EA forms, highlighting
the potential of these moieties as therapeutic and vaccine targets for the treatment of
Chagas’ disease.
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INTRODUCTION
The flagellated protozoan Trypanosoma cruzi is the etiologic agent of Chagas’ disease and is
responsible for an estimated 6–7 million individuals infected worldwide, mostly in Latin America
(World Health Organization [WHO], 2017). This parasite has four defined morphological stages:
two infective forms called metacyclic and bloodstream trypomastigotes and two replicative forms
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known as amastigotes and epimastigotes (Clayton, 2010).
Although T. cruzi amastigotes are usually found in the cytoplasm
of infected cells of the mammalian host, these forms can also
be found in the extracellular milieu due to trypomastigote
differentiation or early lysis of infected cells (Andrews et al.,
1987; Ley et al., 1988) or due to cytolysis at inflamed sites of
infection during the chronic stage of Chagas’ disease (Scharfstein
and Morrot, 1999).
These extracellular amastigotes (EAs) are proxies for their
intracellular counterparts as they share morphological and
immunochemical markers and are capable of invading and
sustaining infection cycles in mammalian cells (Nogueira and
Cohn, 1976; Ley et al., 1988). However, unlike the infective
trypomastigote forms, EAs invade HeLa cells in an actin-
dependent mechanism, forming a phagocytic cup that surrounds
these parasites (Mortara, 1991; Procópio et al., 1999), suggesting
that EAs display functionally distinct membrane proteins that
interact with a different set of host cell receptors. The membrane
proteins on the surfaces of EAs are recognized by host cell
receptors, and the roles of these proteins in actin-dependent
invasion remain elusive.
Kahn et al. (1996) have observed that amastigotes, but
not trypomastigotes or epimastigotes, interact with host
macrophages via mannose surface receptors (MRIs). The cell
surface protein galectin-3 (Gal-3), which belongs to the galectin
family and recognizes β-galactosides, has been previously
implicated in the interaction of T. cruzi with host cell membranes
(Moody et al., 2000; Kleshchenko et al., 2004; Vray et al.,
2004; Pineda et al., 2015). In addition, Machado et al. (2014)
observed the recruitment of galectin-3 at invasion sites of EAs in
macrophage cells.
The EAs from group I strains (such as the G strain) were
found to enter mammalian cells much more efficiently than
parasites from groups II (Y strain) or VI (CL strain) (Fernandes
and Mortara, 2004; Mortara et al., 2005; da Silva et al., 2006;
Fernandes et al., 2007). Different studies have shown that the
expression of protein and carbohydrate epitopes varies between
T. cruzi strains and that these variations are correlated with
parasite infectivity (Mortara et al., 1988, 1992; Verbisck et al.,
1998; da Silva et al., 2006; Yoshida, 2006). We have previously
observed two secreted proteins from EAs, p21 and mevalonate
kinase, that mediate host cell signaling during invasion (da Silva
et al., 2009; Ferreira et al., 2016). EAs also express on their
surfaces a major glycoprotein, stage-specific protein 4 (Ssp-4),
initially described by Andrews et al. (1987). This protein is
gradually released into extracellular milieu, which is mediated
by an endogenous phosphatidylinositol-specific phospholipase
C (PI-PLC) (Andrews et al., 1988). We have demonstrated
that Ssp-4 was also released in membrane trails when EAs
were attached to poly-L-lysine-coated glass (Barros et al., 1996).
Two monoclonal antibodies detect different epitopes of Ssp-
4, mAb2C2 (Andrews et al., 1987) and mAb1D9, this last
one recognizes a carbohydrate epitope (Barros et al., 1997).
Moreover, highly infective EAs from the G strain showed
reduced parasite invasion when incubated with mAb1D9 (da
Silva et al., 2006), suggesting the involvement of Ssp-4 in host cell
invasion.
Although limited in their ability to mimic intracellular
amastigotes, EAs present the same set of stage-specific surface
antigens as Ssp-4 (Andrews et al., 1987), the structural and
functional features of which are not yet fully understood.
In the present report, we have revealed the Ssp-4 protein
sequence and observed a correlation between the expression
of protein and carbohydrate epitopes and the strain infectivity
profile. Our findings suggest that parasite infectivity correlates
with posttranslational modifications in Ssp-4, resulting in the
expression of distinct carbohydrate epitopes on EA surfaces. We
also demonstrated that the highly infective G strain secretes an
Ssp-4 epitope (recognized by mAb1D9) into vesicle trails adhered
to HeLa cells, which may contribute to galectin-3 recruitment
during host cell invasion by EAs.
RESULTS
Ssp-4 Glycosylation Is Associated With
Host Cell Invasion by T. cruzi EAs
Host cell invasion is a property exhibited by EAs of some by
T. cruzi strains maintained in vitro. First, we confirmed that
the parasite strains G and CL can be categorized as infectious
and less-infectious EA strains, respectively, based on HeLa cell
invasion assays. Figure 1A shows that the number of internalized
parasites from the G strain within HeLa cells is two logs higher
(p < 0.001) than the number from the CL strain, allowing us to
classify these strains as infectious and less infectious, respectively.
Next, the expression of Ssp-4 on the surfaces of infectious
and less infectious EAs was assessed by immunofluorescence
using two monoclonal antibodies specific for the Ssp-4 antigen,
namely, mAb2C2 and mAb1D9, the latter being employed to
identify carbohydrate epitopes associated with Ssp-4 (Barros
et al., 1997). The carbohydrate epitope recognized by mAb1D9
is highly expressed in infectious EAs and is absent in less
infectious EAs; conversely, mAb2C2 only recognizes Ssp-4 on
the surfaces of less infectious strains (Figure 1B). This result
was reproduced in EA lysates immunostained with mAb1D9
and mAb2C2 by Western blotting (Figure 1C): while the
carbohydrate epitope recognized by mAb1D9 is completely
absent in the less-infectious CL strain, the epitope recognized by
mAb2C2 is detected in both strains, although this recognition
is weak in EAs of the infectious G strain (Figure 1C,
arrow).
The inverse correlation between the detection of the Ssp-
4 carbohydrate epitope by mAb1D9 and the infectivity of EAs
was investigated using other T. cruzi strains. Figures 2A,B show
the membrane distribution and expression of Ssp-4 epitopes
(detected by mAb2C2 and mAb1D9 by immunofluorescence
and Western blotting, respectively) in T cruzi strains Tc863
(Tc III), Tc1522 (Tc I), and Tc1994 (TcBat) compared with the
infectious G strain (Tc I). Highly infective EAs from the G
and Tc1522 strains presented higher reactivity to mAb1D9 and
lower reactivity to mAb2C2 (Figures 2B,C). Conversely, Tc863
exhibited low infectivity and lacked the carbohydrate epitope
recognized by mAb1D9; however, this strain exhibited strong
reactivity to mAb2C2. Tc1994 (TcBat) showed intermediate
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FIGURE 1 | Ssp-4 epitope expression correlates with infectivity of extracellular amastigotes from the G and CL strains. (A) Number of internalized parasites in 300
cells per coverslip. Extracellular amastigotes (EAs) from the G and CL strains were incubated with HeLa cells (MOI 10:1) for 2 h. Mean and SD are represented in the
graphic. Three independent experiments were performed in duplicate. ∗∗∗p < 0.001. (B) EAs of the G or CL strains immunostained with mAb1D9 and mAb2C2
(green); nuclei and kinetoplasts were labeled with DAPI (blue). White arrows indicate the distribution of Ssp-4 epitopes on parasite cell surfaces. Scale bar: 5 µm.
(C) Western blotting of EAs from the G and CL lysates was incubated with mAb2C2 and mAb1D9. Red arrows indicate the Ssp-4 band. As a control, EA lysates
were incubated with anti-α-tubulin antibody.
infectivity compared with the other isolates and expressed
epitopes recognized with similar strength by both mAb1D9 and
mAb2C2.
Ssp-4 Expression Does Not Correlate
With EA Infectivity
As we have established that the presence of the Ssp-4
carbohydrate epitope recognized by mAb1D9 correlates with
EA infectivity, we sought to identify the Ssp-4 sequence and
evaluate whether the mRNA and protein expression of Ssp-
4 is also correlated with host cell invasion. We employed an
immunoprecipitation assay on lysates of less-infectious EAs
by using either mAb2C2 or control serum and specifically
detected a band of 93 kDa associated with Ssp-4 (Figure 3A).
Western blotting with mAb2C2 confirmed the presence of
a band corresponding to a 93-kDa protein in the mAb2C2
immunoprecipitates that is absent when immunoprecipitation
is performed using control serum (red arrows in Figure 3A).
Immunoprecipitation of G strain lysates using mAb1D9 and
mAb2C2 also detected a band of 93 kDa, which was detected with
mAb1D9. Consistent with this result, IPs from the control serum
were not recognized by mAb2C2 or mAb1D9 (Figure 3B).
The 93 kDa bands were subjected to mass spectrometric
analysis followed by a database search using the T. cruzi
CL Brener (hybrid clone) genome database (Supplementary
Table S1). The mAb2C2 immunoprecipitates from the CL
strain showed high identity with sequences from two CL
Brener haplotypes, namely, TcCLB.507089.170 (Esmeraldo-
like haplotype) and TcCLB.506725.20 (non-Esmeraldo-like
haplotype), with 16% coverage. Both sequences code for the same
67 kDa hypothetical protein. Interestingly, mass spectrometric
analysis of the 93 kDa band from the immunoprecipitation of
the G strain with mAb2C2 and mAb1D9 also identified the
same protein (TcCLB.506725.20) with 19.6 and 17.2% coverage,
respectively (Supplementary Table S1). Proteins identified
by mass spectrometry in the IP of the G strain are listed in
Supplementary Table S2; TcCLB.506725.20 had the highest
score among the proteins.
In silico analysis predicted an N-terminal signal peptide
with high probability, indicating that this protein is secreted
(Figure 3B and Supplementary Figure S1). An enzymatic
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FIGURE 2 | Ssp-4 epitope expression correlates with infectivity of T. cruzi isolates. (A) Immunofluorescence of extracellular amastigotes (EAs) from the G strain and
the Tc863 (863), Tc1994 (1994), and Tc1522 (1522) isolates with mAb1D9 or mAb2C2 (green); nuclei and kinetoplasts were DAPI labeled (blue). White arrows
indicate the distribution of carbohydrate epitopes on parasite cell surfaces. Scale bars: 3 µm. (B) Western blotting of T. cruzi EAs from the G strain and the Tc863,
Tc1994, and Tc1522 isolates (863, 1994, and 1522, respectively) incubated with mAb2C2 and mAb1D9; anti-α-tubulin antibody was used for normalization.
(C) Number of internalized parasites (EAs) in 300 cells per coverslip of T. cruzi isolates. Three independent experiments were performed in triplicate or duplicate.
∗p < 0.05; ∗∗∗p < 0.001.
domain with alpha/beta hydrolase activity, hydrophobic
domains in the N- and C-terminal regions, six potential
N-glycosylation sites, and eight potential O-glycosylation sites
were also predicted by bioinformatics. Although this protein
does not have a classic glycosylphosphatidylinositol (GPI)-
anchor domain, a highly hydrophobic C-terminal domain
of approximately 20 amino acids is predicted, and without
this terminal domain, Ssp-4 has 100% probability of being
anchored to GPI.
The immunogenic peptides of the predicted protein were
assessed by prediction of the tertiary structure of the protein
using homology modeling and threading by two different
algorithms (I-Tasser and Yasara) (Figure 3D). In these models,
the peptides with higher immunogenic potential from the
protein are displayed in different colors (blue, green, red, and
yellow). From the structural analysis, peptides LREFVRSTERNR
(named MAP2, shown in yellow) and EARDQQALTQLR
(shown in green) predicted to be more exposed on the
protein surface compared to peptides LNWGADAKEMYTEYR
(shown in blue) and VGENFDDSWASDLRR (shown in red)
(Supplementary Table S3). Only MAP2 was selected for
polyclonal antibody production in mice. The polyclonal antibody
against the MAP2 peptide reacted with a band of 93 kDa
from EA lysates immunoprecipitated with mAb2C2 (Figure 3E),
confirming that the MAP2 peptide is part of the protein core
of Ssp-4.
These data confirm that the hypothetical protein identified by
mass spectrometry is Ssp-4, as previously identified by mAb2C2
(Andrews et al., 1988). We sequenced nucleotides from the
T. cruzi CL Brener, G and CL strains, and the protein alignment
revealed that the Ssp-4 sequence is well conserved across all
strains and among CL Brener haplotypes, clone Dm28c, and
the Sylvio strain from the genome database (Supplementary
Figure S2A). Protein identity between all strains was analyzed
and was found to be at least 95.7% (Supplementary Figure S2B).
The identified Ssp-4 sequence allowed us to compare the
mRNA expression of Ssp-4 in infectious and less-infectious EA
strains; we observed that Ssp-4 mRNA expression, measured
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FIGURE 3 | Ssp-4 identification by mass spectrometry revealed a hypothetical protein from the CL Brener database that was more highly expressed in the CL strain.
(A) Immunoprecipitation (IP) with mAb2C2 or control serum (CS) in protein extracts of extracellular amastigotes (EAs) from the CL strain was performed in the
presence of protein A-Sepharose. Colloidal Coomassie-stained polyacrylamide gel of the IP with mAb2C2 or CS and Western blotting with mAb2C2 of the whole cell
lysate (WC) from extracellular amastigotes (EAs) of the CL and unbound (UB) fraction and IP of 2C2 and CS. Red arrows indicate the band of 93 kDa. (B) IP
performed with mAb1D9, mAb2C2, and CS in protein extracts of EAs from the G strain. Western blotting of the WC from the G strain and IPs with mAb1D9. Red
arrow indicates the band of 93 kDa. (C) Scheme of the hypothetical protein bearing the Ssp-4 epitope identified by mass spectrometry, revealing domains
encountered by in silico analysis. (D) Structural models of the Ssp-4 putative protein predicted by I-Tasser and Yasara. MAP2 peptides are in yellow. In green, blue,
and red are the other peptides selected by I-Tasser and Yasara model (MAP1, MAP3, and MAP4, respectively). (E) IP of protein extracts of EAs of CL with mAb2C2,
subsequently probed with MAP2 in Western blotting.
by qPCR, is at least twofold higher in less-infectious strains
compared to infectious EAs (Figure 4A). This difference was
confirmed by Western blotting and immunofluorescence with a
MAP2 antibody (Figures 4B,C). Therefore, the invasiveness of
infectious strains is not associated with Ssp-4 mRNA or protein
expression. These data suggest that Ssp-4 glycosylation and
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FIGURE 4 | Ssp-4 protein expression is increased in the less infective strain. (A) Relative mRNA expression of Ssp-4 from extracellular amastigotes (EAs) of the CL
strain compared to EAs from the G strain in three independent experiments performed in triplicate. ∗∗p < 0.01. (B) Whole cell lysates (WC) of EAs of the G and CL
strains were incubated with MAP2 in Western blotting; anti-α-tubulin antibody was used for normalization. Red arrows indicate Ssp-4. (C) Immunofluorescence (IF)
of EAs of the G and CL strains incubated with MAP2 (green); nuclei and kinetoplasts were labeled with DAPI (blue). Scale bar: 5 µm.
carbohydrate epitopes recognized by mAb1D9 could be related
to EAs infectivity.
EAs Secrete Glycosylated Ssp-4 That
May or May Not Be Associated With
Vesicles
Because in silico analysis identified a signal peptide on the Ssp-4
protein core (Figure 3C and Supplementary Figures S1, S2), we
assessed the secretion of the glycosylated form of Ssp-4 (detected
by mAb1D9) using confocal and electron microscopy and SDS–
PAGE/silver staining on EA supernatant fractions.
First, morphological analysis of the microscopy images
revealed that infectious EAs release vesicles to the extracellular
medium, and these vesicles are either attached to poly-L-lysine-
coated substrates or to host cell surfaces (Figures 5A,B). Vesicles
of regular shape (100–200 nm in diameter) are secreted in
trails (Figures 5A,B, arrows). These vesicle trails display the
carbohydrate epitope recognized by mAb1D9 and are shed locally
at sites of close contact between EAs and host cells, characterized
by phagocytic cups formed by host cell actin (Figure 5C and
Supplementary Figure S3).
These phagocytic cups associated with the interactions of
infectious EAs are also rich in galectin-3 (Gal-3); Figure 6A
shows that the actin of the phagocytic cup and Gal-3 colocalize
in regions of interaction between host cells and infectious EAs
tagged with mAb1D9. The host cell origin of Gal-3 was confirmed
by Western blotting on extracts of host cells or EAs alone and
of host cells interacting with EAs (Figure 6B). Additionally, host
cells infected by EAs present 20% more Gal-3 than non-infected
host cells (Figure 6B). The direct interaction between the Ssp-
4 carbohydrate epitope recognized by mAb1D9 and host cell
Gal-3 was assessed by immunoprecipitation using anti-Gal-3;
Figure 6C shows that only the lysates of infected host cells
presented reactivity with mAb1D9 (red arrow), indicating that
the carbohydrate epitope recognized by mAb1D9 and displayed
on Ssp-4 is a β-galactoside, with which Gal-3 is known to
specifically interact (Hughes, 1999).
After demonstrating that the carbohydrate moiety of Ssp-4
is a β-galactoside that can be recognized by host cell surface
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FIGURE 5 | Extracellular amastigotes release Ssp-4 associated with vesicles interacting with host cell. (A) Scanning electron microscopy of extracellular amastigotes
(EAs) adhered to coverslips coated with poly-L-lysine or Vero cells. Scale bars: 2 and 5 µm. (B) Transmission electron microscopy of HeLa cells incubated for 30 min
with EAs from the G strain (colored in red). Scale bar: 1 µm. Black arrows indicate EA secreted vesicles. (C) Immunofluorescence of HeLa cells incubated for 30 min
with EAs from G (MOI 10:1) and mAb1D9 (green), DAPI (blue), and phalloidin-TRITC (red). Upper panels: images of a focal plane showing vesicles secreted by EAs of
the G strain (green) associated with actin (red); bottom panels: three-dimensional reconstruction from a Z-series acquired by a confocal microscope. Scale bar:
2 µm. Arrows indicate vesicular structures secreted by EAs. (D) Extracellular amastigotes (EAs) from the G and Y strains were incubated for 6 h in RPMI medium
without fetal bovine serum. Supernatant was collected and fractionated in three different populations: V2 (pelleted after 2 h of ultracentrifugation), V16 (pelleted after
16 h ultracentrifugation), and VF (supernatant from pellet V16). Western blotting with mAb1D9 and silver-stained SDS–PAGE of the different fractions. Whole cell
(WC) lysate of EAs of the G strain was used as control.
components and is secreted in vesicles during interactions
with host cells at sites of EA invasion, we evaluated whether
glycosylated Ssp-4 could also be found in vesicle-free fractions of
infectious EA supernatants (Figure 5D). Fractions were obtained
by ultracentrifugation of the EA supernatant after 2 or 16 h,
resulting in precipitates containing ectosomes (V2 fraction)
and exosomes (V16 fraction), respectively. The remaining
supernatant is considered free of vesicles (VF fraction).
Figure 5D shows that although SDS–PAGE/silver staining
demonstrated different protein profiles between supernatant
populations, glycosylated Ssp-4 was detected by mAb1D9
in all three fractions, demonstrating that infectious EAs
release either free glycosylated Ssp-4 or glycosylated Ssp-4
in association with different secreted vesicles. No differences
in electrophoretic mobility were observed between vesicle-
free and vesicle-associated Ssp-4 protein. This finding is
consistent with previous observations about the T. cruzi
secretome from metacyclic typomastigotes, where the stage-
specific GPI-anchored protein GP82 detected in vesicle-free
fractions had a mobility profile that matched that of the
protein present in vesicle-enriched fractions (Bayer-Santos et al.,
2013).
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FIGURE 6 | Galectin-3 is recruited to extracellular amastigotes from the G strain at sites of invasion and interacts with the Ssp-4 carbohydrate epitope recognized by
mAb1D9. (A) Immunofluorescence with mAb1D9 (blue) and anti-Gal-3 (green). HeLa cells were incubated with extracellular amastigotes (EAs) from the G strain (MOI
10:1) for 30 min. The actin cytoskeleton was labeled with 647 phalloidin (red), and DAPI (white) was used to label nuclei and kinetoplasts. White arrows indicate EAs
surrounded by actin and Gal-3. Scale bar: 5 µm. (B) Western blotting of EAs interacting with HeLa cells performed with anti-Gal-3 and mAb1D9. Samples were
normalized with anti-α-actin. HeLa cells were incubated with EAs of the G strain (MOI 40:1) for 40 min. Whole cell (WC) lysate from infected cells (H+G), and controls
only from HeLa (H) and EAs of the G strain (G) were obtained. (C) Immunoprecipitation (IP) was performed for H+G and controls of H and G lysates with anti-Gal-3
coupled to protein G-Sepharose. Red arrow indicates the band that reacted with mAb1D9 on the IP H+G.
DISCUSSION
Mortara et al. (1999) first established correlation between Ssp-
4 recognition by mAb1D9 and EA infectivity by demonstrating
that EAs of more infective strains present higher reactivity with
mAb1D9. However, da Silva et al. (2006) did not observe the
same correlation between mAb1D9 reactivity and EA infectivity
in isolates from chagasic patients. Although correlation was
not demonstrated, the authors verified that blockage of the
carbohydrate epitope with mAb1D9 could inhibit EA invasion,
suggesting a role for carbohydrate moieties of Ssp-4 in host
cell invasion. We confirmed the correlation between the Ssp-4
carbohydrate epitope recognized by mAb1D9 and EA infectivity,
adding these observations to those from the sequencing of the
Ssp-4 protein core, the measurement of the expression of this
protein in infectious versus less-infectious EAs and the analysis of
the nature and function of the carbohydrate moieties in parasite
infectivity.
The EAs from the most infective strains, G and clone Tc1552,
which belong to the same phylogenetic group (Tc I), exhibited
high reactivity with mAb1D9 and low reactivity with mAb2C2
(Figures 1, 2). Conversely, less-infectious EAs, such as those of
the CL strain (Tc VI) and the Tc863 isolate (Tc III), showed high
reactivity with mAb2C2 and low reactivity with mAb1D9. These
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results suggest that the post-translational modifications of Ssp-4
differ among T. cruzi strains, and this phenotype directly reflects
parasite infectivity.
The first description of Ssp-4 revealed that mAb2C2
recognizes a surface GPI-anchored glycoprotein, which is
cleaved and released into extracellular milieu in the presence
of PI-PLC (Andrews et al., 1988). Subsequently, Olivas-
Rubio et al. (2009) identified a partial sequence from the
DGF-1 multigenic family, but identification of potential
domains on the putative protein was challenging. These
challenges led us to identify Ssp-4 using approaches other than
immunostaining, such as mass spectrometry (MS) of mAb2C2-
and mAb1D9-immunoprecipitated proteins, protein sequencing
with bioinformatic analysis and quantitative PCR.
Based on the CL Brener hybrid clone genomic database,
haplotype sequences encode a hypothetical protein that is highly
expressed (mRNA and protein) in amastigote forms (Atwood
et al., 2005; Minning et al., 2009). Additionally, Ssp-4 sequences
exhibit homology with a hypothetical protein from Trypanosoma
rangeli and Leishmania ssp., but not Trypanosoma brucei, which
indicates that these proteins could be associated with the presence
of an intracellular cycle defined by the amastigote form. In
silico analysis of the amino acid sequences identified by MS
led to the identification of Ssp-4 domains previously described
by Andrews et al. (1988) as potential sites to be targeted to
the plasma membrane and secreted, i.e., the presence of N-
and O-glycosylation sites and a possible GPI-anchor. Potential
glycosylation sites observed explain the fact that hypothetical
protein encountered by MS present 67 kDa, and by Western
blotting molecular weight detect a band between 93 kDa. Finally,
an α/β-hydrolase motif was identified. Previous study found that
the trypomastigote surface prolyl oligopeptidase (POP) enzyme
(Tc80), which contains an α/β-hydrolase domain, is capable of
hydrolyzing substrates such as fibronectin and collagen and was
shown to be involved in non-phagocytic cell invasion (Bastos
et al., 2005). However, the enzymatic functions of this feature of
Ssp-4 were not investigated, and the contribution of this enzyme
to host cell invasion remains unclear.
To confirm our MS data, a polyclonal antibody (MAP2) was
produced based on the tertiary structure of Ssp-4 (Figure 3C). In
this set of results, it was observed that MAP2 reacts with mAb2C2
immunoprecipitates (mAb2C2-IPs) from less infectious EAs
(Figure 3E). These data strongly suggest that the protein detected
by mass spectrometry is the Ssp-4 that was previously described
by Andrews et al. (1988). Immunostaining using the MAP2
antibody detected higher expression of Ssp-4 on non-infectious
EAs, suggesting again that recognition of the carbohydrate
epitope on Ssp-4 by mAb1D9 can hinder the interactions of
the protein core epitopes (Figure 4B). The production of the
MAP2 antibody, obtained after chemical synthesis of peptides
generated by bioinformatics and protein modeling, confirms the
antigenic potential of Ssp-4 and renders feasible the production
of an efficient and safe vaccine against Chagas’ disease using a
combination of the Ssp-4 protein core and carbohydrate moieties
(Quijano-Hernandez and Dumonteil, 2011; Ma et al., 2015).
The hypothetical protein (TcCLB.506725.20) identified by MS
and considered here to be Ssp-4 was previously detected by
our group in microarray assays. In the previous experiments,
a 21-kDa protein (P21) and a mevalonate kinase (MVK) were
also detected, being more highly expressed in the infectious
EAs of the G strain than in the less-infectious CL strain; these
two factors were shown to contribute to host cell invasion (da
Silva et al., 2009; Ferreira et al., 2016). Here, we confirmed by
quantitative PCR that Ssp-4 is more highly expressed in less-
infectious strains (Figure 4A), although infectious EAs exhibit
a highly glycosylated Ssp-4 (as revealed by mAb1D9). Thus,
we concluded that even though Ssp-4 provides the substrate
for other posttranslational modifications, host cell invasion
is not determined by Ssp-4 protein expression alone but by
glycosylation of Ssp-4 (Figure 4).
Considering that glycosylated Ssp-4 is secreted and that
infectious EAs secrete large amounts of vesicle trails when
adhered to poly-L-lysine surfaces covered by glycosylated Ssp-4
or mammalian host cell surfaces (Figures 5A,B) (Barros et al.,
1996), we investigated whether or not Ssp-4 interacted with
these vesicles to modulate EA infection by either inhibiting
or promoting host cell invasion. A recent study observed a
similar pattern of secreted vesicles from flagellar membranes
of Trypanosoma brucei that act as carriers of virulence factors,
contributing to host immune evasion and erythrocyte remodeling
(Szempruch et al., 2016). First, vesicles displaying glycosylated
Ssp-4 are secreted locally at sites of EA-host-cell interaction,
namely, the phagocytic cup formed during the process of EA
internalization, suggesting that these vesicles could be recognized
by host cell receptors and could ultimately promote host cell
invasion. Therefore, we sought to identify a possible receptor
that could bind to carbohydrates displayed by Ssp-4. Several
groups have demonstrated that Gal-3 participates in host cell
infection by T. cruzi; Machado et al. (2014) observed the
recruitment of Gal-3 during invasion and after parasitic escape
from vacuoles in peritoneal macrophages infected with EAs
of the G strain. Considering that EAs are internalized by
non-professional phagocytes via an actin-dependent process
similar to phagocytosis (Mortara, 1991; Procópio et al., 1998;
Fernandes et al., 2013) and that Gal-3 has been shown to
play a crucial role during phagocytosis in macrophages (Sano
et al., 2003), we investigated the association of Gal-3 with
the Ssp-4 carbohydrate epitope recognized by mAb1D9 during
host cell invasion by EAs. We have demonstrated that Gal-
3 is recruited to the EA entry site (Figure 6A), is more
abundant in infected cells than in uninfected cells (Figure 6B)
and co-immunoprecipitates with Ssp-4 recognized by mAb1D9
(Figure 6C). As Gal-3 specifically recognizes β-galactosides, we
concluded that a β-galactose antigen displayed by Ssp-4 is the
carbohydrate moiety recognized by host cells. Exogenous Gal-
3 is able to activate Rac-1 in corneal epithelial cells (Saravanan
et al., 2009). Interestingly, our group has previously revealed
the participation of proteins associated with the Rho-GTPase
family, such as Rac-1, in EA internalization (Fernandes and
Mortara, 2004; Bonfim-Melo et al., 2018). Members of these
families are responsible for mediating the recruitment of the
actin cytoskeleton with cell surface receptors. Thus, increased
Gal-3 availability could mediate Rac-1 activation and formation
of phagocytic cups involved in host cell invasion of EAs.
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We have shown that post-translational modifications of
surface proteins of T. cruzi EAs are more closely associated
with parasite infectivity than the expression of the protein core.
Additionally, glycosylated Ssp-4 can form a bridge between the
parasite and host cell surface factors such as Gal-3, triggering
EA internalization. In our model, we have shown that protein
glycosylation plays a central role in the control of EA host
cell invasion, highlighting the importance of post-translational
modifications. The results of this study may contribute to the
development of therapeutic agents and vaccines for the treatment
of Chagas’ disease.
MATERIALS AND METHODS
Host Cells
HeLa cells and Vero cells (Instituto Adolfo Lutz, São Paulo,
Brazil) were cultivated by successive passaging in RPMI 1640
medium (Atena Biotecnologia) supplemented with 10% heat-
inactivated fetal bovine serum (FBS; Vitrocell), 100 U/mL
penicillin and 100 µg/mL streptomycin (Sigma-Aldrich).
Parasites
In this study, parasites from the G (Tc I) (Yoshida, 1983) and
CL (Tc VI) strains (Brener and Chiari, 1963) were used. New
isolates of T. cruzi were also used: the Tc863 (Tc III) isolate
and clones Tc1522 (José strain; Tc I) and Tc1994 (Tcbat). These
previously classified/typed isolates were a gift from Dr. Marta
M. Geraldes Teixeira (ICB-USP, Trypanosomatid Bank). T. cruzi
trypomastigote forms were collected from the supernatants
of Vero cells cultivated with RPMI medium supplemented
with 2.5% heat-inactivated FBS. The trypomastigotes were then
incubated with liver infusion tryptose (Camargo, 1964) medium
(pH 5.8) supplemented with 10% FBS for 16 h to obtain EAs
(Tomlinson et al., 1995).
Ssp-4 Antibodies
Monoclonal antibody (mAb) 2C2, which recognizes an epitope of
Ssp-4, was a gift from Norma Andrews (University of Maryland)
(Andrews et al., 1987). The antibody mAb1D9 was obtained by
immunization of BALB/c mice with amastigotes from clone D11
(derived from G strain).
Peptides (Bio-Synthesis Inc.) were synthesized based on
the Ssp-4 tertiary structure modeled by homology modeling
and threading (described in section “Molecular Modeling and
Structural Analyses”). We selected non-conjugated multiple
antigenic peptide sequence (LREFVRSTERNR) for animal
immunization. Briefly, solubilized peptides (1 mg/mL) in
phosphate-buffered saline (PBS; 137 mM NaCl, 10 mM
phosphate, 2.7 mM KCl, pH 7.4) were inoculated into BALB/c
mice in the presence of Freund’s complete or incomplete
adjuvant (Sigma-Aldrich). Four immunizations (100 µL peptide
solution/mouse) were performed intraperitoneally with 7-day
interval. These mice were euthanized with lethal injections of
ketamine/xylazine (250/50 mg/kg per mouse) 1 week after the last
immunization. Then, cardiac puncture was performed on these
mice, and the collected blood was centrifuged at 1,200 × g for
5 min to obtain serum containing polyclonal antibodies (MAP2).
Control serum was obtained as a negative control by caudal vein
puncture before the first immunization. All animal procedures
were approved by the local ethics committee (No. 1465020616).
Immunoprecipitation
Ssp-4 was immunoprecipitated (IP) using protein A-Sepharose
(Sigma-Aldrich) with mAb2C2 (IgG2a). Lysate was prepared
from 109 EAs of the CL or G strains with lysis buffer (50 mM
Tris–HCl, 150 mM NaCl, 1% Triton X-100, pH 7.4). The
lysate was then incubated with protein A-Sepharose for 1 h
at 4◦C for pre-clearing. Next, the supernatant from the pre-
clearing was incubated with protein A-Sepharose and mAb2C2
(1:5, ascitic fluid) overnight at 4◦C. After incubation, the pellet
containing protein A-Sepharose attached to mAb2C2 and Ssp-
4 was washed with washing buffer (20 mM Tris–HCl, pH 7.5)
with different NaCl concentrations (0.5, 0.3, 0.1 M). The pellet
was then resuspended with 4 × SDS–PAGE sample buffer
(0.1 M Tris–HCl, 10% SDS, 0.5 mM bromophenol blue, 10%
glycerol, 12% β-mercaptoethanol, pH 6.8). As a control, we used
a non-immune mouse serum for immunoprecipitation instead
of mAb2C2. Alternatively, immunoprecipitation was performed
using EAs from the G strain lysate with mAb1D9 (IgG3) and
protein G-Sepharose (Sigma-Aldrich).
Mass Spectrometric Analysis
The IPs from the EAs of the CL strain with mAb2C2 and
the control serum (CS) and IPs from the EAs of the G
strain with mAb2C2, mAb1D9, and CS were subjected to
SDS–PAGE and stained with colloidal Coomassie. The band
of 93 kDa from all mAb2C2 and CS IPs were excised from
the gel and destained with 50 mM ammonium bicarbonate
in 50% acetonitrile (ACN) solution. Then, the bands were
dehydrated with 100% ACN. Proteins were reduced with 10 mM
dithiothreitol and alkylated with 50 mM iodoacetamide. Gel
bands were washed with 50 mM NH4HCO3/50% ACN and then
with 100% ACN. The bands were then incubated with porcine
trypsin (Sigma-Aldrich) solution (400 ng) for 16 h at 37◦C
for protein digestion. The resulting peptides were resuspended
in 0.1% formic acid, and an aliquot (4.5 µL) was injected
into a Q-TOF Ultima mass spectrometer (Waters) coupled
to a nano-chromatography system (nanoACQUITY, Waters).
Samples were desalted and concentrated using a pre-column
(Symmetry C18, 180 µm × 20 mm, Waters) and eluted onto a
capillary reversed-phase C18 column (10 cm × 75 µm, Waters)
at a flow rate of 600 nL/min. Peptides were fractionated with
a linear gradient from 5 to 40% ACN in 0.1% formic acid
for 15 min. The eluted peptides were directly injected into the
mass spectrometer (MS) via an electrospray. The MS spectrum
of phosphoric acid was acquired simultaneously to acquisition
of the sample spectra. The MS/MS spectra of the three most
intense peaks with two to four charges in the MS function
were automatically acquired in the data-dependent acquisition
(DDA) mode. The capillary voltage and reference cone were set
at 3.2 kV and 100 V, respectively. All analyses were performed
in positive ion mode. The spectra were acquired from 50 to
2000 m/z.
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Peptides from the IPs of the G strain were injected onto an
LTQ-Orbitrap Velos (Thermo). Masses from the raw Q-TOF files
were corrected using a lock mass of m/z 784.823, and the raw data
were converted to the .pkl format using the ProteinLynx Global
Server (Waters). Orbitrap raw files were converted into .mgf
files using MSConverter. Searches were performed in MASCOT
(2.4.1 version) against a Trypanosoma cruzi CL Brener database
(downloaded in 2017/05, 21,169 sequences) by considering a
peptide and fragment mass tolerance of 0.5 Da (for Q-TOF files)
and peptide and fragment mass tolerance of 10 ppm and 0.6 Da,
respectively. Carbamidomethylation of cysteine and oxidation
of methionine residues were specified as fixed and variable
modifications, respectively. To obtain a final list of identified
proteins, masses smaller than 60 kDa and higher than 110 kDa
were excluded as were proteins identified as control samples.
Finally, proteins identified with scores lower than 80 were also
excluded.
In Silico Analysis
Bioinformatics was performed using the ExPASy1 platform. The
signal peptide was predicted by SignalP v. 4.1. The TargetP v. 1.1
platform was used to predict subcellular location. Hydrophobic
domains were predicted by the TMHMM 2.0 server. Potential
sites of N- and O-glycosylation were identified by NetNGlyc
1.0 and NetOGlyc 4.0, respectively. Interproscan v. 4.8 software
was used to identify different protein domains. Prediction of
GPI-anchoring sites was performed with the PredGPI2 program.
Cloning of the Ssp-4 Coding Sequence
The open reading frame encoding the putative Ssp-4 protein
identified by mass spectrometry was amplified by PCR using
T. cruzi genomic DNA as a template. The amplification was
performed using the Ssp4F (5′-atggctctaaagagtatgcggaaa-3′) and
Ssp4R (5′-ttaatggttcaaattgctgtaaaa-3′) oligonucleotides and Pfu
DNA polymerase (Fermentas).
Amplicons from the G and CL strains and the CL Brener
clone were resolved on agarose gels, and the bands at the
expected size were excised and purified. Purified amplicons
were A-tailed prior to ligation into the pGEM R©-T Easy vector
(Promega). Plasmid DNA isolated from positive clones was
sequenced on an ABI3500 genetic analyzer (Applied Biosystems)
using the BigDye R© Terminator v3.1 Cycle Sequencing Kit (Life
Technologies). Sequences were aligned by BioEdit v. 7.2.5 using
the ClustalW algorithm. The assembled nucleotide sequences
encoding the putative Ssp-4 protein from the G and CL strains
were deposited in GenBank under accession numbers KX581696
and KX581697, respectively.
Relative Quantification of mRNA by
Real-Time PCR (qPCR)
For real-time quantitative PCR (qPCR), we synthesized the
following primers: GAPDH Forward (5′-agcgcgcgtctaagacttaca-
3′) and Reverse (5′-tggagctgcggttgtcatt-3) (Cordero et al., 2008)
1www.expasy.org
2http://gpcr.biocomp.unibo.it/predgpi/pred.htm
and Ssp-4 Forward (5′-cctctgacattgacccgttatt-3′) and Reverse (5′-
gtaagttggattggtgtggta-3′). RNA extraction from the EAs of the G
and CL strains was performed with the RNeasy Protect Mini Kit
(Qiagen). Next, cDNA was generated using the High-Capacity
cDNA Reverse Transcription Kit (Applied Biosystems). Relative
quantification was monitored by intercalation of SYBRTM Green
Master Mix (Life Technologies) in the double-stranded DNA in
qPCR reactions; normalized values calculated with a 11cycle
threshold (Ct) and relative expression (2−11Ct ) with the G strain
as a reference are shown. GAPDH is the housekeeping gene; this
gene is constitutively expressed in T. cruzi.
Molecular Modeling and Structural
Analyses
The three-dimensional structure of the putative Ssp-4 sequenced
by mass spectrometry was modeled using I-Tasser (Yang et al.,
2015) and Yasara3. The model with the highest C-score from
I-Tasser and the hybrid model from Yasara were selected for
structural analysis. The solvent-accessible surface area (SASA) of
each amino acid was calculated using DSSP 2.2.1 (Touw et al.,
2015). The most exposed peptides in both models were selected as
the most immunogenic peptides to be synthesized (Bio-Synthesis
Inc.) for the production of the antibody against the Ssp-4 protein
region (section “Ssp-4 Antibodies”).
Western Blotting
The EA lysates (20 µg) were incubated with 4 × sample buffer
and subjected to SDS–PAGE (Laemmli, 1970). Proteins from
the gel were transferred to nitrocellulose membranes to perform
the immunoblotting (Towbin et al., 1979). Membranes were
blocked for 1 h with ECL blocking agent (GE Healthcare), TBS
(50 mM Tris–HCl, 150 mM NaCl, pH 7.4), and TBS-T (TBS
with 0.1% Tween 20). Then, nitrocellulose membranes were
incubated with mAb1D9 (1:500, ascites), mAb2C2 (1:500 ascites),
MAP2 (1:500, mouse antiserum), or anti-α-tubulin (1:1000,
Sigma-Aldrich) overnight with 5% bovine serum albumin
(Sigma-Aldrich) in TBS-T. Next, the membranes were incubated
for 1 h with a secondary antibody, anti-mouse IgG-peroxidase
(Sigma-Aldrich), and visualized by a chemiluminescence detector
(UVITEC) in the presence of luminol with the ECL Prime
Western blotting detection reagent (GE Healthcare).
Transmission and Scanning Electron
Microscopy
HeLa cells incubated with EAs for 30 min were fixed with
2.5% glutaraldehyde and 2% formaldehyde in 0.1 M sodium
cacodylate buffer at room temperature for 1 h and then processed
for transmission electron microscopy (TEM) according to
procedures described elsewhere (Arruda et al., 2012). Cells were
observed in a JEOL 1200 EXII electron microscope (JEOL Ltd.,
Peabody, MA, United States). For scanning electron microscopy
(SEM), EAs adhered to Vero cells or to coverslips covered
with 0.1% poly-L-lysine (Sigma-Aldrich) were fixed with 4%
paraformaldehyde, washed with 0.1 M cacodylate solution, post-
fixed with osmium tetroxide, treated with tannic acid, dehydrated
3www.yasara.org
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with ethanol, dried in a critical point dryer (Bal-Tec AG, Balzers,
Liechtenstein), and sputtered with gold. Samples were observed
in an FEI Quanta FEG 250 SEM (Hillsboro, OR, United States).
Parasites Immunofluorescence and
Confocal Imaging
The EAs were attached to coverslips covered with 0.1%
poly-L-lysine (Sigma-Aldrich) for 50 min or HeLa cells for
30 min at 37◦C and fixed with 4% paraformaldehyde. After
fixation, coverslips were incubated with blocking solution,
PGN (0.2% gelatin, 0.1% NaN3, diluted in PBS), for 1 h.
Next, samples were incubated with mAb1D9, mAb2C2 (1:100),
or MAP2 (1:100) diluted in PGN supplemented with 0.25%
saponin (PGN-S; Sigma-Aldrich) for 1 h at room temperature.
Next, coverslips were incubated with a secondary antibody,
Alexa Fluor 488 IgG-mouse (Invitrogen), diluted in PGN-S
(1:100) for 1 h at room temperature. Coverslips were then
incubated with 1 µM 4′,6-diamidino-2-phenylindole (DAPI)
for 15 min. After three washes with PBS, coverslips were
mounted in glycerol buffered with 0.1 M Tris (pH 8.6) and 0.1%
p-phenylenediamine. Samples were examined by a Leica TCS SP5
confocal system (Leica Microsystems, Wetzlar, Germany) using a
100 × NA 1:44 oil immersion objective. Images were processed
by Imaris software (Bitplane AG, Andor Technology, Belfast,
United Kingdom).
EA Supernatant Fractionation
The EAs supernatant fractionation was adapted from Bayer-
Santos et al. (2013). Briefly, parasites from the G strain
were incubated in RPMI medium without FBS for 6 h at
37◦C (108 EAs/mL). Then, the parasites were removed by
centrifugation at 3,000 × g for 10 min, and supernatant
was collected. The supernatant was filtered by using a 0.45-
µm-pore membrane and subjected to ultracentrifugation at
100,000 × g for 2 h to obtain the first pellet, which was enriched
with larger vesicles (V2). The supernatant resulting from this
ultracentrifugation was again subjected to ultracentrifugation
at 100,000 × g for 16 h to generate the second pellet, which
was enriched with smaller vesicles (V16), and the supernatant
contained vesicle-free soluble (VF) proteins.
Infection of Host Cells
Suspension containing 105 HeLa cells in RPMI supplemented
with 10% FBS per well (24-well plate) was plated on coverslips
and incubated overnight at 37◦C in CO2 (5%). Next, EAs
(Multiplicity of Infection; MOI: 10:1) were added for 2 h at
37◦C. After incubation, the cells were washed 5–7 times with
PBS. Then, the cells were fixed with Bouin’s solution (Sigma-
Aldrich) for 5 min and stained with Giemsa for 1 h (da Silva et al.,
2006). Internalized parasites were quantified by light microscopy
(Bonfim-Melo et al., 2015).
Alternatively, EAs were added to HeLa cells adhered to 6-
well plates and incubated for 40 min at 37◦C in CO2 (5%).
An immunofluorescence assay was performed on the coverslips;
after EA (MOI 10:1) incubation, the cells were washed with
PBS and fixed with 4% paraformaldehyde (PFA) for 15 min.
Then, the coverslips were incubated with the primary antibodies
mAb1D9 (mouse IgG) and anti-Galectin-3 (rat IgG; a gift from
Dr. Roger Chammas, Universidade de São Paulo) for 1 h at
room temperature. Next, the samples were incubated with the
secondary antibodies Alexa Fluor IgG mouse 488 and Alexa
Fluor IgG rat 568 in the presence of 1 µm DAPI (Invitrogen)
and 200 units/mL phalloidin 647 (Invitrogen) for 1 h at room
temperature.
For Western blotting, EAs (MOI 40:1) were incubated with
HeLa cells for 40 min at 37◦C in CO2 (5%). Infected HeLa
cells, control non-infected HeLa cells, and EA suspensions
were lysed with lysis buffer (50 mM Tris–HCl, 150 mM
NaCl, 1% Triton X-100, pH 7.4) for 30 min at 4◦C. Samples
were subjected to Western blotting with primary antibodies
anti-Gal-3 (1:250), mAb1D9 (1:500), and anti-α-actin (1:1000;
Cell Signaling), and then, immunoprecipitation with anti-Gal-3
and protein G-Sepharose (Sigma-Aldrich) was performed as
described above. Band densitometry was analyzed by UVIBAND
image quantification software.
Statistics
All results are representative of three independent experiments
with at least two biological replicates. Excel and GraphPad
Prism 4.0 were employed for data plotting and statistical
analysis. Statistical tests included Student’s t-test and
ANOVA, and a statistical threshold of p < 0.05 was
used.
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FIGURE S1 | In silico analysis of the Ssp-4 sequence. Analysis of the Ssp-4
protein sequence identified by mass spectrometry using the ExPASy platform. The
results obtained from the server are as follows: (A) prediction of signal peptide
(SignalP v. 4.1); (B) prediction of transmembrane helices (TMHMM v. 2.0); (C)
prediction of GPI-anchor (PredGPI); (D) prediction of subcellular localization
(TargetP v. 1.1); (E) Interproscan v. 4.8; (F) prediction of N-glycosylation (NetNGlyc
v. 1.0); and (G) prediction of O-glycosylation (NetOGlyc v. 4.0).
FIGURE S2 | Ssp-4 protein alignment revealed a conserved backbone between
different T. cruzi strains. (A) Sequences were aligned in the BioEdit program using
the ClustalW algorithm. Regions with 100% identity between the sequences are
shown in black. White and gray regions represent amino acid divergence in at
least one of the aligned sequences. In the legend, 1 and 2 represent the
Esmeraldo-like haplotype and non-Esmeraldo-like haplotypes from the CL Brener
database, respectively; 3 and 4 represent Dm28c and Sylvio database
sequences, respectively; 5, 6 and 7 represent Ssp-4 coding sequences from
the CL Brener clone and the G and CL strains isolated in this study, respectively.
(B) Protein identity and divergence scores between all strains aligned.
FIGURE S3 | Vesicle trails covered with Ssp-4 carbohydrate epitopes on EAs of
the G strain adhered to poly-L-lysine. Extracellular amastigotes (EAs) were
attached onto coverslips coated with poly-L-lysine for 50 min at 37◦C. Then, the
parasites were fixed with 4% paraformaldehyde and incubated with blocking
solution for 1 h. Samples were incubated with mAb1D9 (green) and DAPI (blue).
Left panels: immunofluorescence images obtained from one plane. Arrows
indicate released vesicle trails from parasites. Right panels: Differential interference
contrast (DIC). Scale bar: 2 µm.
TABLE S1 | Proteins and peptides identified by mass spectrometry.
TABLE S2 | List of identified proteins from EAs of the G strain immunoprecipitated
with mAb2C2 and mAb1D9.
TABLE S3 | Solvent-accessible surface area (SASA). The solvent-accessible
surface area (SASA) for each amino acid predicted by DSSP 2.2.1.
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